Allspring Global Investments’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,468
Closed -$22.1K 2558
2024
Q2
$22.1K Buy
+5,468
New +$23.4K ﹤0.01% 2103
2023
Q4
Sell
-1,301
Closed -$13.3K 2608
2023
Q3
$13.3K Buy
1,301
+800
+160% +$9.87K ﹤0.01% 2581
2023
Q2
$6.91K Sell
501
-2,905
-85% -$43.6K ﹤0.01% 2563
2023
Q1
$55.3K Sell
3,406
-1,325
-28% -$25K ﹤0.01% 2258
2022
Q4
$83.7K Sell
4,731
-2,432
-34% -$48.3K ﹤0.01% 2139
2022
Q3
$139K Buy
7,163
+2,059
+40% +$43.7K ﹤0.01% 1949
2022
Q2
$101K Sell
5,104
-7,291
-59% -$163K ﹤0.01% 2063
2022
Q1
$319K Buy
12,395
+3,103
+33% +$80.5K ﹤0.01% 2418
2021
Q4
$234K Buy
+9,292
New +$257K ﹤0.01% 2592

Other funds holding PETS

Allspring Global Investments's PETS Position: Q3 2024 in Review

Allspring Global Investments sold out of PetMed Express (PETS) in Q3 2024, closing a stake of 5,468 shares — an estimated $22.1K sold.

Allspring Global Investments first reported a position in PETS in Q4 2021 and held it in 9 quarters. The position peaked at $319K in Q1 2022. 93 funds tracked by Wall St. Rank hold PETS as of Q3 2024.

  • Allspring Global Investments reported no remaining PetMed Express position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 5,468 PetMed Express shares in Q3 2024, an estimated $22.1K.
  • Allspring Global Investments first reported a position in PetMed Express in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's PetMed Express position peaked at $319K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held PetMed Express as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.